Breaking News

LSNE Completes Two FDA Inspections

FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lyophilization Services of New England (LSNE) has completed two FDA inspections of their aseptic manufacturing facilities. These inspections were conducted in January and February of 2017. The first inspection was an FDA Pre-Approval Inspection (PAI) of their aseptic manufacturing facility located at Commerce Drive in Bedford, NH. As a result, the Commerce Drive facility has been recommended for approval to manufacture the commercial sterile drug product for U.S. distribution.   This PAI, which ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters